medigraphic.com
Órgano Oficial del Hospital Angeles Health System

2022, Number 1

<< Back Next >>

Acta Med 2022; 20 (1)

Gallbladder cancer as a histopathological finding after cholecystectomy. Prevalence and incidence at thirteen years in Hospital Angeles Pedregal

Aizpuru EM, Cázares RTK, Castillo GJJ, León MG, Gallegos GAC, Flandes AI, De IME

Language: Spanish
References: 20
Page: 37-42
PDF size: 191.49 Kb.


ABSTRACT

Introduction: Gallbladder carcinoma (GC), first described in 1777, ranks sixth in the frequency of malignancies in the gastrointestinal tract. Objective: To determine the prevalence and incidence of GC in patients after cholecystectomy at Hospital Angeles Pedregal. Material and methods: We conducted a descriptive, observational, retrospective, and cross-sectional study of clinical records of patients undergoing cholecystectomy, including a total of 6,954 cholecystectomies for thirteen years. Histological reports were collected and analyzed to obtain GC prevalence and incidence. Results: Sixteen patients of the 6,954 studied cases were diagnosed with GC (0.23%), with a prevalence of 0.23 cases per 100 cholecystectomies and with an incidence of 2.3 for every 1,000 subjects. Adenocarcinoma was the most common histopathological diagnosis with 15 cases, and only one neuroendocrine tumor. Preoperative GC diagnosis was suspected in only two of the 16 patients with malignancy (12.5%). Conclusions: The incidence of GC in our hospital is located below the lower limits reported in the literature. Preoperative suspicion is also under the rates estimated worldwide; therefore, ultrasound and computerized tomography can raise the percentage of preoperatively GC detection.


REFERENCES

  1. Maegawa FB, Ashouri Y, Hamidi M, Hsu CH, Riall TS. Gallbladder cancer surgery in the United States: lymphadenectomy trends and impact on survival. J Surg Res [Internet]. 2021; 258: 54-63. Available in: https://doi.org/10.1016/j.jss.2020.08.041

  2. Andrén-Sandberg A, Deng Y. Aspects on gallbladder cancer in 2014. Curr Opin Gastroenterol. 2014; 30 (3): 326-331.

  3. Kanlioz M, Ekici U, Ayva Y. Analysis of incidental gallbladder cancer in cholecystectomies. Cureus. 2019; 11 (9): e5710.

  4. Muszynska C, Nilsson J, Lundgren L, Lindell G, Andersson R, Sandstrom P et al. A risk score model to predict incidental gallbladder cancer in patients scheduled for cholecystectomy. Am J Surg. 2020; 220 (3): 741-744.

  5. Sharma A, Sharma KL, Gupta A, Yadav A, Kumar A. Gallbladder cancer epidemiology, pathogenesis and molecular genetics: Recent update. World J Gastroenterol. 2017; 23 (22): 3978-3998.

  6. Hickman L, Contreras C. Gallbladder cancer: diagnosis, surgical management, and adjuvant therapies. Surg Clin North Am [Internet]. 2019; 99 (2): 337-355. Available in: https://doi.org/10.1016/j.suc.2018.12.008

  7. Wrenn SM, Callas PW, Abu-Jaish W. Histopathological examination of specimen following cholecystectomy: Are we accepting resect and discard? Surg Endosc. 2017; 31 (2): 586-593.

  8. Chan NC, Bandín MA, Villalobos BI, Torres MA. Guía de práctica clínica. Cáncer de vesícula biliar. México: Asociación Mexicana de Cirugía General; 2014.

  9. Edition S. AJCC Cancer Staging Manual. AJCC Cancer Staging Manual. 2017.

  10. Schmidt MA, Marcano-Bonilla L, Roberts LR. Gallbladder cancer: epidemiology and genetic risk associations. Chin Clin Oncol. 2019; 8 (4): 31.

  11. Noriega UVM, Álvarez SM, Hernández MR, Rodríguez LR, Bieletto TEO, Fenig RJ. Carcinoma de vesícula biliar incidental después de colecistectomía. Análisis de los hallazgos patológicos a cinco años. Acta Med. 2016; 14 (4): 196-200.

  12. Castillo GJJ, Romo AC, Ruiz LJ, Escrivá MJF, Córdova PVH. Cáncer de vesícula biliar como hallazgo histopatológico posterior a la colecistectomía. Prevalencia e incidencia en el Hospital Ángeles Pedregal. Acta Med. 2010; 8 (3): 140-147.

  13. Aristi UG, Pérez-Peña Díaz-Conti M, Soto AMV. Carcinoma de vesícula biliar: una neoplasia subestimada. Rev Med Hosp Gen Mex. 1999; 62 (2): 94-101.

  14. Ramírez CP, Suárez MA, Santoyo J, Fernández JL, Jiménez M, Pérez JA et al. Actualización del diagnóstico y el tratamiento del cáncer de vesícula biliar. Cir Esp. 2002; 71: 102-111.

  15. Butte JM, Gonen M, Allen PJ, D'Angelica MI, Kingham TP, Fong Y et al. The role of laparoscopic staging in patients with incidental gallbladder cancer. HPB (Oxford). 2011; 13 (7): 463-472.

  16. Levy AD, Murakata LA, Rohrmann CA Jr. Gallbladder carcinoma: radiologic-pathologic correlation. Radiographics. 2001; 21 (2): 295-314.

  17. Bhuta P, Brown MG, Alderdice JM. Gall bladder cancer--radical surgery, the key role to improve outcome. Ulster Med J. 2002; 71 (2): 128-131.

  18. Reid KM, Ramos-De la Medina A, Donohue JH. Diagnosis and surgical management of gallbladder cancer: a review. J Gastrointest Surg. 2007; 11 (5): 671-681.

  19. Mghirbi F, Ayadi M, Karray W, Yahyaoui Y, Meddeb K, Mokrani A et al. Squamous cell carcinoma of the gallbladder. Transl Gastroenterol Hepatol. 2016; 1: 78.

  20. Regimbeau JM, Fuks D, Bachellier P, Le Treut YP, Pruvot FR, Navarro F et al. Prognostic value of jaundice in patients with gallbladder cancer by the AFC-GBC-2009 study group. Eur J Surg Oncol [Internet]. 2011; 37 (6): 505-512. Available in: http://dx.doi.org/10.1016/j.ejso.2011.03.135




2020     |     www.medigraphic.com